Note: Astellas US's revenues are gauged from an analysis of company filings.
Astellas US's Income Statement (based on Industry Averages)
Astellas US P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Astellas US is developing and marketing.
Astellas US doesn't have any recent trademark applications, indicating Astellas US is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
OPTION -VMS Providing medical information
09/22/2023
VYMZEA Pharmaceutical preparations for the treatment and management of vasomotor symptoms and conditions associated with menopause
08/23/2022
VYMMS Pharmaceutical preparations for the treatment and management of vasomotor symptoms and conditions associated with menopause
08/23/2022
See all trademarks and details in the Full Report.
Market Share of Astellas US's Largest Competitors
A competitive analysis shows these companies are in the same general field as Astellas US, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Astellas US.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Astellas US and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.